DCGI approves three COVID vaccines for kids aged above five years
The approval has been granted to Covaxin, ZyCov-D and Corbevax
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
ZyCoV-D
‘The Lancet’ publishes phase-III data of ZyCoV-D
The results of the phase-I part of the phase-I/II clinical trial have already been published in the e-Clinical Medicine Journal of…
Zydus supplies the first consignment of its COVID-19 vaccine ZyCoV-D
ZyCoV-D is a three-dose vaccine administered intradermally using the painless PharmaJet needle-free system, Tropis, on day zero,…
ZyCoV-D to be used in seven states initially
The seven states are Bihar, Jharkhand, Maharashtra, Punjab, Tamil Nadu, Uttar Pradesh and West Bengal
Centre places purchase order for one crore doses of Zydus Cadila’s needle-free COVID vaccine
ZyCoV-D is the first vaccine cleared by India's drug regulator for inoculation of those aged 12 years and above
DCGI gives nod to Cadila Healthcare to conduct phase-III trials for two-dose COVID vaccine
The company has already received the Emergency Use Authorisation (EUA) from the Drug Controller General of India (DCGI) for…
Government to introduce ZyCoV-D shortly
ZyCoV-D has received the Emergency Use Authorisation from the Drugs Controller General of India (DCGI) and will be administered to…
DCGI gives nod for Biological E’s COVID-19 vaccine’s phase-II/III trials on kids aged…
The trial will be conducted across 10 sites in the country
Zydus Cadila’s COVID vaccine ZyCoV-D gets approval for Emergency Use Authorisation
With EUA, ZyCoV-D has also become the first vaccine to be administered to those in the age group of 12-18 years in the country
ZyCoV-D may find favour in 12-18 age group for COVID-19 vaccination in India: GlobalData
ZyCoV-D’s Phase III interim analysis has shown efficacy of 66.6 per cent and was conducted in over 28,000 subjects, including 1000…